Litcius/Paper detail

Alzheimer’s disease: Lecanemab gets full FDA approval and black box safety warning

Elisabeth Mahase

2023BMJ48 citationsDOI

Topics & Concepts

Black boxMedicineDiseaseComputer sciencePathologyArtificial intelligenceCholinesterase and Neurodegenerative DiseasesHealth Systems, Economic Evaluations, Quality of LifeAlzheimer's disease research and treatments
Alzheimer’s disease: Lecanemab gets full FDA approval and black box safety warning | Litcius